JAGUAR HEALTH, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
JAGUAR HEALTH, INC. (JAGX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 168.94 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-19
- JAGUAR HEALTH, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 299.50K shares, a 59.13% decline year-over-year.
- JAGUAR HEALTH, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 732.81K shares, a 89.96% decline year-over-year.
- JAGUAR HEALTH, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 7.30M shares, a 8650.11% increase year-over-year.
- JAGUAR HEALTH, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 83.39K shares, a 3.66% increase year-over-year.
- JAGUAR HEALTH, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 51.43K shares, a 532.05% increase from fiscal 2023.
- JAGUAR HEALTH, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 8.14K shares, a 89.89% decline from fiscal 2022.
- JAGUAR HEALTH, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 80.45K shares, a 70.09% increase from fiscal 2021.
- JAGUAR HEALTH, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 47.30K shares, a 98.80% decline from fiscal 2020.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 168.94K shares 10-Q · filed 2026-08-19 | |||||||
| 2026-03-31 | 299.50K shares 10-Q · filed 2026-05-20 | |||||||
| 2025-12-31 | 116.79K shares 10-Q · filed 2026-08-19 | 4.09M shares 10-K · filed 2026-04-07 | ||||||
| 2025-09-30 | 2.95M shares 10-Q · filed 2025-11-14 | |||||||
| 2025-06-30 | 2.16M shares 10-Q · filed 2025-08-14 | |||||||
| 2025-03-31 | 732.81K shares 10-Q · filed 2025-05-15 | |||||||
| 2024-12-31 | 51.43K shares 10-K · filed 2026-04-07 | |||||||
| 2024-09-30 | 97.39K shares 10-Q · filed 2024-11-13 | |||||||
| 2024-06-30 | 122.39K shares 10-Q · filed 2024-08-13 | |||||||
| 2024-03-31 | 7.30M shares 10-Q · filed 2024-05-14 | |||||||
| 2023-12-31 | 8.14K shares 10-K · filed 2025-03-31 | 14.16M shares 10-K · filed 2024-04-01 | ||||||
| 2023-09-30 | 11.49M shares 10-Q · filed 2023-11-14 | |||||||
| 2023-06-30 | 10.74M shares 10-Q · filed 2023-08-14 | |||||||
| 2023-03-31 | 83.39K shares 10-Q · filed 2023-05-15 | |||||||
| 2022-12-31 | 80.45K shares 10-K · filed 2024-04-01 | |||||||
| 2022-09-30 | 6.38M shares 10-Q · filed 2022-11-14 | |||||||
| 2022-06-30 | 6.39M shares 10-Q · filed 2022-08-22 | |||||||
| 2022-03-31 | 80.45K shares 10-Q · filed 2023-05-15 | 6.48M shares 10-Q · filed 2022-05-10 | ||||||
| 2021-12-31 | 47.30K shares 10-K · filed 2023-03-24 | 3.55M shares 10-K · filed 2022-03-11 | ||||||
| 2021-09-30 | 3.02M shares 10-Q · filed 2022-11-14 | |||||||
| 2021-06-30 | 3.55M shares 10-Q · filed 2022-08-22 | 9.07M shares 10-Q · filed 2021-08-13 | ||||||
| 2021-03-31 | 3.55M shares 10-Q · filed 2022-05-10 | 6.22M shares 10-Q · filed 2021-05-17 | ||||||
| 2020-12-31 | 3.93M shares 10-K · filed 2022-03-11 | 11.78M shares 10-K · filed 2021-03-31 | ||||||
| 2020-09-30 | 4.43M shares 10-Q · filed 2021-11-17 | 13.29M shares 10-Q · filed 2020-11-16 | ||||||
| 2020-06-30 | 23.36M shares 10-Q · filed 2021-08-13 | |||||||
| 2020-03-31 | 28.46M shares 10-Q · filed 2021-05-17 | |||||||
| 2019-12-31 | 26.72M shares 10-K · filed 2021-03-31 | 26.72M shares 10-K · filed 2020-04-03 | ||||||
| 2019-09-30 | 24.71M shares 10-Q · filed 2020-11-16 | 25.26M shares 10-Q · filed 2019-11-14 | ||||||
| 2019-06-30 | 1.76M shares 10-Q · filed 2020-08-13 | |||||||
| 2019-03-31 | 33.28M shares 10-Q · filed 2020-05-15 | 42.38M shares 10-Q · filed 2019-05-21 | ||||||
| 2018-12-31 | 129.71K shares 10-K · filed 2020-04-03 | 5.76M shares 10-K · filed 2019-04-10 | ||||||
| 2018-09-30 | 95.04K shares 10-Q · filed 2019-11-14 | |||||||
| 2018-06-30 | 3.41M shares 10-Q · filed 2019-08-14 | |||||||
| 2018-03-31 | 5.83M shares 10-Q · filed 2019-05-21 | 26.36M shares 10-Q · filed 2018-05-15 | ||||||
| 2017-12-31 | 14.16M shares 10-K · filed 2019-04-10 | |||||||
| 2017-09-30 | 9.64M shares 10-Q · filed 2017-11-20 | |||||||
| 2017-06-30 | 8.80M shares 10-Q · filed 2017-08-09 | |||||||
| 2017-03-31 | 8.89M shares 10-Q · filed 2018-05-15 | |||||||
| 2016-12-31 | 8.56M shares 10-K · filed 2018-04-09 | |||||||
| 2016-09-30 | 3.18M shares 10-Q · filed 2017-11-20 | |||||||
| 2016-06-30 | 2.23M shares 10-Q · filed 2017-08-09 | |||||||
| 2016-03-31 | 1.66M shares 10-Q/A · filed 2017-06-23 | |||||||
| 2015-12-31 | 1.72M shares 10-K · filed 2017-02-15 | |||||||
| 2015-09-30 | 1.65M shares 10-Q · filed 2016-11-14 | 1.51M shares 10-Q · filed 2015-11-13 | ||||||
| 2015-06-30 | 1.62M shares 10-Q · filed 2016-08-15 | 1.48M shares 10-Q · filed 2015-08-13 | ||||||
| 2015-03-31 | 3.23M shares 10-Q · filed 2016-05-10 | |||||||
| 2014-12-31 | 3.23M shares 10-K · filed 2016-03-29 | |||||||
| 2014-09-30 | 3.10M shares 10-Q · filed 2015-11-13 | |||||||
| 2014-06-30 | 3.07M shares 10-Q · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |